SenzaGen provides state-of-the-art animal-free tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.

GLP Compliant Laboratory

Skin Sensitizing Hazard

GARD®skin and GARD®skin Medical Device are robust in vitro tests to identify potential chemical skin sensitizers with broad applicability and over 90% prediction accuracy.

Skin Sensitizing Potency

GARD®skin Dose-Response and GARD®potency are robust in vitro tests for qualitative and quatantative skin sensitizing potency assessment.

Respiratory Sensitization

GARD®air is the only commercially available in vitro test capable of identifying chemical respiratory sensitizers. The test is recommended for use as an R&D tool.

Press Releases

14 Dec, 2017
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
08 Sep, 2017
News
IR
English
Corporate Information
Other Corporate Information

Subscribe


Prenumerera